ORGANOPlus Reports First-Ever Preclinical Anti-Cancer Data for Bifidobacteria-Derived Candidate OP820

• ORGANOPlus presented first-ever preclinical anti-cancer data for its Bifidobacteria-derived candidate OP820 at ACLAB 15 in Taipei.

• The company is preparing to establish a Denmark subsidiary to advance global collaborations and expand its European presence.